Wells, W.
, Barker, P.
, Macaulay, C.
, Novelli, M.
, Levenson, R.
and Crawford, J.
(2007),
Validation of Novel Optical Imaging Modalities: The Pathologists' View, Journal of Biomedical Optics
(Accessed January 17, 2025)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Validation of Novel Optical Imaging Modalities: The Pathologists' View
Published
Author(s)
W Wells, , C Macaulay, M Novelli, Richard Levenson, J Crawford
Abstract
Recent advances in optical imaging technology have the potential to improve the accuracy of disease detection and predict treatment response. The critical end-point for the success of any new imaging technology is clinical outcome. The following review considers the validation of novel optical imaging standards from a pathologist s point of view. A pathologist can provide a critical link between ensuring that appropriate biopsy tissue is acquired for both the disease diagnosis and for image correlation studies using biomarkers derived from pathology gold standards. We will consider the selection of such validation biomarkers; pathology standardization in tissue processing, diagnosis, reporting and quantitative analysis; and reference standards, controls and data inter-compatibility between institutions.Citation
Journal of Biomedical Optics
Volume
12
Issue
5
Pub Type
Journals
Keywords
bioimaging, optical imaging, quantitative histopathology, standards
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.
Created September 30, 2007, Updated October 12, 2021